欣妈富隆品牌怎么样 申请店铺

超低剂量去氧孕烯炔雌醇片，源自妈富隆品牌，全球知名短效口服避孕药，短效避孕药中雌激素含量超低且被广泛应用的口服避孕药品牌

妈富隆是现代全球短效避孕药的翘楚，迄今已经有多年的历史，避孕性高，是全球97个国家爱侣的放心之选，帮你远离意外怀孕的担忧。1994年，妈富隆口服避孕药由荷兰欧加农制药公司带到中国。

妈富隆于1981年进入欧洲，现已成为世界上应用广泛的口服避孕药品牌之一。妈富隆避孕效果良好，‘妈富隆’因其独特的孕激素成分，克服了以往国产口服避孕药的雄激素副作用，其它副作用发生率很低。欧美发达国家，口服避孕药在育龄妇女中的使用率一直很高，在30%-40%之间。目前，全球约有7千万5百万妇女正在服用妈富隆，其应用已非常广泛，它在1992年已获得美国食品和药物管理局（FDA）的批准。畅销于全球114个国家和地区。截止到1998年，妈富隆全球销量已超过9亿板。

美国时间2007年3月12 日，先灵葆雅公司（纽约证券交易所简称：SGP）宣布，该公司董事会批准了一项交易。根据该交易，先灵葆雅将以大约110亿欧元现金（根据2007年3月9 日收市汇率折合144亿美元），收购阿克苏—诺贝尔公司的人用药品与动物健康产品业务 ―― 欧加农(ORGANON)生物科技。

2014年05月08日，拜耳正式与默沙东公司(MRK.NYSE，在美国和加拿大称为默克)达成协议，将以142亿美元的价格收购后者的健康消费品业务，其中包括其明星产品抗过敏药物开瑞坦(Claritin)和鼻血管收缩药阿氟林(Afrin)。

The ultra-low dose oxypregnene ethinylestradiol tablet, originated from Marvelon brand, is a world-famous short acting oral contraceptive. Marvelon, an oral contraceptive brand with ultra-low estrogen content and widely used, is the leader of modern short acting contraceptives in the world. It has a history of many years so far. It is a safe choice for lovers in 97 countries to help you stay away from unwanted pregnancy Worries. In 1994, the oral contraceptive pill of Marvelon was brought to China by the Netherlands oganon pharmaceutical company. Marvelon entered Europe in 1981 and has become one of the most widely used oral contraceptive brands in the world. Marvelon has a good contraceptive effect. Because of its unique progesterone composition, Marvelon overcomes the androgen side effects of domestic oral contraceptives, and the incidence of other side effects is very low. In developed countries in Europe and America, the use rate of oral contraceptives in women of childbearing age has been very high, between 30% and 40%. Currently, about 75 million women around the world are taking Marvelon, which has been widely used. It was approved by the U.S. Food and Drug Administration (FDA) in 1992. Best selling in 114 countries and regions around the world. As of 1998, the global sales volume of Marvelon has exceeded 900 million boards. On March 12, 2007, Schering plough announced that its board of directors had approved a transaction. Under the deal, Schering plough will acquire organon biotechnology, Akzo Nobel's human drugs and animal health products business, in cash of about 11 billion euros (US $14.4 billion at the closing exchange rate on March 9, 2007). On May 8, 2014, Bayer officially reached an agreement with mrk.nyse (known as Merck in the United States and Canada) to acquire the latter's health consumer goods business at a price of US $14.2 billion, including claritin, its star product anti allergy drug, and Afrin, a nasal blood tube constrictor.

本文链接： https://brand.waitui.com/a136aef07.html 联系电话：400-890-1828,800-810-1828